- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06568497
Dairy and Vegan Cheese: Effect on Satiety and Blood Glucose
August 22, 2025 updated by: Mount Saint Vincent University
Sensory, Satiating and Glycaemic Characteristics of Cheese and Non-dairy Alternative Products to Cheese
The project will consist of two studies.
One study will explore the satiating properties of dairy cheese and its dairy-free substitute when consumed ad libidum, and another study will investigate their effects on postprandial glycemia.
Both studies will involve healthy young adults.
The secondary outcomes of these studies will be food sensory characteristics, diet-induced thermogenesis, subjective feeling of fatigue and energy, gastrointestinal comfort level, and food intake.
The proposed project results will help to better understand the health properties of the cheese and its dairy-free substitute.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bohdan Luhovyy, PhD
- Phone Number: 902221380
- Email: Bohdan.Luhovyy@msvu.ca
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3M 2J6
- Recruiting
- Mount Saint Vincent University
-
Contact:
- Bohdan Luhovyy, PhD
- Phone Number: 902-457-6256
- Email: bohdan.luhovyy@msvu.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Young healthy adults
Exclusion Criteria:
- Breakfast skipper
- Smoker (including e-cigarettes) / cannabis consumer
- Be underweight, overweight or obese
- Have chronic diseases, including diabetes
- Taking certain medication
- Have lactose intolerance, food allergies or gastrointestinal disorders (e.g., irritable bowel syndrome, or others).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dairy
A food containing dairy cheese
|
Food
|
|
Experimental: Non-Dairy
A food containing vegan alternative to cheese
|
Food
|
|
Experimental: Conrtol
A control treatment in the form of food
|
Food
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satiety
Time Frame: 0-120 minutes
|
The components of average subjective appetite including desire to eat, hunger, fullness, and a prospective food consumption measured with 100mm visual analogue scales.
|
0-120 minutes
|
|
Blood glucose
Time Frame: 0-120 minutes
|
The concentrations of blood glucose
|
0-120 minutes
|
|
Insulin
Time Frame: 0-120 minutes
|
The concentrations of insulin
|
0-120 minutes
|
|
Food intake
Time Frame: 0 minutes, 120 minutes
|
Energy intake with an ad libitum meal at 120 minutes
|
0 minutes, 120 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Energy and Fatigue
Time Frame: 0-120 minutes
|
Subjective perception of feeling energetic and fatigue
|
0-120 minutes
|
|
Gastrointestinal comfort
Time Frame: 0-120 minutes
|
The subjective feeling of wellness and gastrointestinal discomfort parameters including the feeling of nausea, stomach cramps, flatulency, diarrhea and a subjective feeling of wellness, each measured with 100mm visual analogue scales.
|
0-120 minutes
|
|
Diet-induced thermogenesis
Time Frame: 0-120 minutes
|
Indirect calorimetry
|
0-120 minutes
|
|
Sensory characteristics
Time Frame: 0 minutes, 120 minutes
|
The perception of pleasantness of the treatments (0 minutes) and a test meal (at 120 minutes) will be measured with 9-point hedonic and 100mm visual analogue scales.
|
0 minutes, 120 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 4, 2024
Primary Completion (Estimated)
August 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
August 1, 2024
First Submitted That Met QC Criteria
August 20, 2024
First Posted (Actual)
August 23, 2024
Study Record Updates
Last Update Posted (Estimated)
August 29, 2025
Last Update Submitted That Met QC Criteria
August 22, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-147
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Glucose
-
Wageningen University and ResearchCompletedGlucose, Low Blood | Glucose, High BloodNetherlands
-
Inland Norway University of Applied SciencesUniversity of OsloCompletedBlood Glucose | Blood Glucose Related VariablesNorway
-
Ingredion IncorporatedKGK Science Inc.CompletedGlucose, Low Blood | Glucose, High Blood | Meals
-
Matthew GroutCompletedMood | Cognitive Performance | Glucose, Low Blood | Glucose, High BloodUnited Kingdom
-
Weizmann Institute of ScienceCompletedGlucose Intolerance | Glucose, Low Blood | Glucose, High BloodIsrael
-
Matthew GroutCompletedDiet Modification | Mood | Glucose, Low Blood | Glucose, High Blood
-
Ocean Spray Cranberries, Inc.Biofortis Innovation ServicesRecruiting
-
Ocean Spray Cranberries, Inc.CompletedBlood Glucose | Blood InsulinUnited States
-
University of ManitobaAgriculture and Agri-Food CanadaCompleted
-
University of CopenhagenDaniscoCompleted
Clinical Trials on Food
-
Mount Saint Vincent UniversityCompletedBlood Glucose | Eating | Food | AppetiteCanada
-
NYU Langone HealthNational Cancer Institute (NCI); New York University; National Institutes of...RecruitingCalorie ConsumptionUnited States
-
Mount Saint Vincent UniversityCompletedEating | Satiety | Food | Physical ComfortCanada
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | Diabetes MellitusSingapore
-
National Institute of Diabetes and Digestive and...CompletedObesity | Healthy DietUnited States
-
Mount Saint Vincent UniversityCompletedEating | Food | AppetiteCanada
-
NYU Langone HealthRecruitingCalorie ConsumptionUnited States
-
PepsiCo Global R&DNot yet recruiting
-
CargillCompleted